Daily Antiplatelets Other Than Aspirin Reduce Liver Cancer Risk but Increase Intracranial Hemorrhage Risk in Cirrhotic Patients

Daily Antiplatelets Other Than Aspirin Reduce Liver Cancer Risk but Increase Intracranial Hemorrhage Risk in Cirrhotic Patients

Chern-Horng Lee,1 Cheng-Li Lin,2 Tzung-Hai Yen,3 Sen-Yung Hsieh4,5 1Department of Geriatric Medicine and General Internal Medicine, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan; 2Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan; 3Department of Ne...

Full description

Bibliographic Details
Main Authors: Lee CH, Lin CL, Yen TH, Hsieh SY
Format: Article
Language:English
Published: Dove Medical Press 2024-10-01
Series:International Journal of General Medicine
Subjects:
cirrhosis
antiplatelet agents
hepatocellular carcinoma
intracranial hemorrhage
mortality.
Online Access:https://www.dovepress.com/daily-antiplatelets-other-than-aspirin-reduce-liver-cancer-risk-but-in-peer-reviewed-fulltext-article-IJGM

Internet

https://www.dovepress.com/daily-antiplatelets-other-than-aspirin-reduce-liver-cancer-risk-but-in-peer-reviewed-fulltext-article-IJGM

Similar Items